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Abstract
Purpose To refine methods that assess structural brain abnormalities and calculate intracranial volumes in fetuses with congenital
heart diseases (CHD) using in utero MR (iuMR) imaging. Our secondary objective was to assess the prevalence of brain
abnormalities in this high-risk cohort and compare the brain volumes with normative values.
Methods We performed iuMR on 16 pregnant women carrying a fetus with CHD and gestational age ≥ 28-week gestation and no
brain abnormality on ultrasonography. All cases had fetal echocardiography by a pediatric cardiologist. Structural brain abnor-
malities on iuMRwere recorded. Intracranial volumes were made from 3D FIESTA acquisitions following manual segmentation
and the use of 3D Slicer software and were compared with normal fetuses. Z scores were calculated, and regression analyses were
performed to look for differences between the normal and CHD fetuses.
Results Successful 2D and 3D volume imaging was obtained in all 16 cases within a 30-min scan. Despite normal ultrasonog-
raphy, 5/16 fetuses (31%) had structural brain abnormalities detected by iuMR (3 with ventriculomegaly, 2 with vermian
hypoplasia). Brain volume, extra-axial volume, and total intracranial volume were statistically significantly reduced, while
ventricular volumes were increased in the CHD cohort.
Conclusion We have shown that it is possible to perform detailed 2D and 3D studies using iuMR that allow thorough investi-
gation of all intracranial compartments in fetuses with CHD in a clinically appropriate scan time. Those fetuses have a high risk of
structural brain abnormalities and smaller brain volumes even when brain ultrasonography is normal.
Keywords Fetus .Magnetic resonance imaging . Congenital heart disease . Brain abnormality
Introduction
Congenital heart disease (CHD) is the commonest develop-
mental abnormality in live births (prevalence 8/1000) and the
likeliest to cause death [1]. Improved treatment, particularly
surgical repair, has greatly improved long-term survival
resulting in an increased prevalence of CHD in adults to ap-
proximately 4/1000 [2]. Up to 50% of children with severe
CHD have some degree of neuro-developmental difficulty
[3–8], and the American Heart Association recommends serial
neuro-developmental screening and monitoring for those at
highest risk [9]. The etiology of the neuro-developmental
problems is complex and multifactorial; undoubtedly, compli-
cations from surgery [9–13] contribute but known pre- and
peri-operative risk factors are thought to account for around
30% of poor neuro-developmental outcomes.
The multifactorial etiology of neuro-developmental prob-
lems in children with CHD was reviewed recently by Seed
[14] who stated that there is likely to be morbidity because of
undiagnosed chromosomal or monogenetic anomalies as well
as peri-operative brain injury. Seed primarily discusses the
significance of acquired brain injury in the fetus and child with
CHD, but a recent systematic review has examined the
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prevalence of prenatal brain abnormalities in fetuses with
CHD [15]. Three studies, with 221 cases, were suitable for
inclusion in that review and reported a 28% rate of structural
brain abnormalities in fetuses with CHD. This included devel-
opmental brain abnormalities, reductions in brain volume, and
changes in metabolism, maturation, and brain blood flow.
Two illustrative examples from our clinical practice are shown
in Figs. 1 and 2.
In utero MR (iuMR) imaging is now a recognized clinical
method for assessing the fetal brain, and a recent study
(MERIDIAN) showed clear improvements in diagnostic ac-
curacy and confidence for iuMR over ante-natal ultrasonogra-
phy (USS), with an absolute improvement in diagnostic accu-
racy of > 22% [16]. It is important to note, however, that
entrance criteria for MERIDIAN required a brain abnormality
to be present on USS. Fetuses with CHD might be considered
at Bincreased risk^ of a brain abnormality, but the majority of
USS studies will be normal; therefore, the results of
MERIDIAN are not directly transferable to fetuses with CHD.
The first aim of this study was to trial an iuMRprotocol that
can obtain high-quality images of the fetal brain using routine
ultrafast 2D sequences in order to see if this brings about any
improvement in diagnostic accuracy when compared with the
current clinical standard (USS). In addition, we will devise a
method of obtaining volume estimates of the intracranial com-
partments using recently developed 3D MR methods in order
to see if such measurements are feasible in a clinical setting
and to look for changes in the volume of intracranial compart-
ments in pregnancies complicated by fetal CHD.
Methods
Funding, ethical approval, and participants
The work reported here was supported by the NIHR-HTA by
way of an extension to the main MERIDIAN study [16] and
conducted under the same ethics approval (IRAS 62734) and
clinical trials regulations (ISRCTN 27626961). Pregnant
women who were interested in coming into the study were
contacted by research staff from the Academic Unit of
Radiology, University of Sheffield and were sent a patient
information leaflet by email or post. A follow-up telephone
call enabled queries to be answered, initial screening questions
to be assessed, and eligibility for the studies confirmed.
General inclusion criteria were as follows: the woman was at
least 16 years old and the fetus must be a minimum of 18
gestational weeks (gw) at the time iuMR imaging was per-
formed. Exclusion criteria consisted of inability to give in-
formed consent, contraindications to MR imaging, or
inability/unwillingness to travel to Sheffield for iuMR imag-
ing. Written informed consent was taken on the day of the
study. Participants were not paid for the study, but travel ex-
penses were reimbursed.
Fetuses with CHD
Fetuses with CHD were recruited from a single tertiary center
(University Hospitals of Leicester) after referral from other
regional centers and district general hospitals for fetal echo-
cardiography, which was performed by experienced pediatric
cardiologists with extensive experience in fetal echocardiog-
raphy. All cases included in the study were first identified at
20 gw and were offered invasive procedures to check chro-
mosomal make-up of the fetuses and had formal assessment of
the brain by a fetal medicine specialist in the tertiary center.
Pregnant women whose singleton fetus had a confirmed CHD
(excluding Bsimple^ cardiac defects, such as right aortic arch
and isolated anomalies of venous drainage) were invited into
the study provided that there was no structural brain abnor-
mality on ante-natal USS and no known genetic or chromo-
somal abnormalities. The formal approach to come into the
study was made following a follow-up ultrasound scan at 27–
28-week gestation if they fulfilled all of the inclusion and
exclusion criteria.
Fig. 1 A fetus with known
atrioventricular septal defect and
growth restriction but no brain
abnormality on USS (not
included in the present study).
Microcephaly, agenesis of the
corpus callosum (a coronal) with
an inter-hemispheric cyst (b
axial), and hypotelorism (c axial)
were shown on iuMR imaging at
25 gestational weeks
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Normal fetuses
We had previously created and reported a normative database
of 200 women by scanning fetuses from low-risk pregnancies;
no structural abnormality (brain or somatic) was recognized
on ultrasonography, and no brain abnormality was seen on
iuMR between 18 and 37 gw [17]. Those participants were
informed about the study by way of posters and leaflets in 12/
16 of the fetal medicine referral centers involved in the orig-
inal MERIDIAN study [16]. These fetuses of appropriate
gestational age from this group provided the normative data
by which the fetuses with CHD in the current were compared.
MR technique and image processing
All iuMR imaging studies were performed on the same 1.5-T
whole body scanner (HDx, GE Healthcare, Milwaukee) using
an eight-channel cardiac coil positioned over the maternal
abdomen. Our standard range of clinical iuMR sequences
was performed in accordance with the methods described
Fig. 2 A fetus with known truncus arteriosus and Bsmall cavum septum
pellucidum^ on USS (not included in the present study). Routine 2D
iuMR images at 21 gestational weeks (a coronal and b axial) and a
superior view of the brain surface created from 3D volume imaging (c)
show microcephaly/micrencephaly, non-separation of the cerebral
hemispheres, and hypoplasia of the frontal lobe diagnostic of semilobar
holoprosencephaly
Table 1 Summaries of the iuMR imaging findings of the brains of 16 fetuses with CHD
Case Cardiac abnormality Gestational
age at iuMR
Structural brain
abnormality on iuMR
VV (Z score) BPV (Z score) EAV (Z score) TICV (Z score)
1 Transposition of the great arteries
Atrioventricular septal defects
36w No + 1.4 0.0 − 1.3 + 0.7
2 Transposition of the great arteries
Double outlet right ventricle
33w Vermian hypoplasia,
Mild ventriculomegaly
+ 3.0 − 0.7 − 2.1 − 1.3
3 Transposition of the great arteries
Double outlet right ventricle
28w No − 1.1 − 1.2 − 1.1 − 1.9
4 Transposition of the great arteries 33w No + 1.3 − 0.3 − 3.3 − 2.0
5 Transposition of the great arteries
Double outlet right ventricle
29w Vermian hypoplasia + 1.8 − 1.3 − 1.9 − 1.6
6 Tetralogy of Fallot 31w No − 0.7 − 2.0 − 3.2 − 3.0
7 Tetralogy of Fallot 31w No + 0.9 − 4.1 − 5.0 − 5.1
8 Tetralogy of Fallot 31w Mild ventriculomegaly + 1.9 − 2.8 − 3.9 − 3.7
9 Hypoplastic left heart syndrome 32w No − 1.0 − 1.7 − 1.4 − 1.9
10 Hypoplastic left heart syndrome 30w No + 0.5 − 0.6 + 0.3 − 0.4
11 Hypoplastic left heart syndrome 34w Moderate ventriculomegaly + 7.8 − 3.0 − 1.5 − 4.0
12 Ventricular septal defect,
pulmonary stenosis
32w No − 0.6 + 0.4 − 0.5 − 0.1
13 Uhl’s anomaly 34w No + 1.9 0.0 − 1.5 − 1.4
14 Atrioventricular septal defects 33w No + 0.2 − 2.5 − 3.1 − 4.4
15 Ventricular septal defect 34w Mild ventriculomegaly + 3.9 + 0.6 + 0.1 + 0.9
16 Aortic arch hypoplasia 35w No + 0.1 + 1.8 − 1.9 + 0.3
Mild ventriculomegaly is defined as trigone measurements of 10–12 mm and moderate ventriculomegaly as trigone measurements of 13–15-mm
inclusive. VV = ventricular volume, BPV = brain parenchymal volume, EAV = extra-axial volume, TICV = total intracranial volume
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previously [16], and these provided the basis of either
confirming normality of the brain or the definition of the brain
pathology. In all cases, 3D balanced, steady-state sequences
(fast imaging employing steady-state acquisitions—FIESTA)
were obtained in the axial plane of the fetal brain. This tech-
nique of producing 3D images of the fetal brain has been
described in detail previously [18, 19]; but to summarise, the
imaging parameters were TR 4 ms, TE 2 m, flip angle 60°,
field of view of 320 mm× 260 mm, and an acquisition matrix
of 320 × 256. A number of partitions and partition thickness
were adjusted according to the size of the individual brain,
with the aim of acquiring each dataset with the highest reso-
lution possible without increasing the scan time (in the order
of 20–24 s). Typical partition thickness was 1.8 to 2.6 mm
with resultant voxel sizes of 0.6 × 0.5 × 1–1.3 mm after
interpolation.
The 3D imaging datasets were transferred to a standard
personal computer and loaded into 3D Slicer (http://www.
slicer.org). Note that 3D Slicer does not have CE marking,
so the results can only be used for research purposes. The
brightness and contrast levels were user-selected to opti-
mize visualisation of the CSF/brain interfaces, and the
fetal brain was manually segmented. First, the ventricular
compartment is segmented and the ventricular volume
(VV) is calculated, followed by segmentation of the ex-
ternal brain surface in order to calculate the brain paren-
chymal volume (BPV), which excludes the CSF in the
ventricles. The internal surface of the skull is segmented
in order to calculate the extra-axial volume (EAV), and
lastly, the three volumes are summated to derive total
intracranial volume (TICV).
Image interpretation and analysis
The iuMR studies were reviewed by an experienced pedi-
atric neuroradiologist (PDG), and if no structural brain
abnormality was identified, a letter reporting Bno unex-
pected findings^ was sent to the woman’s general
practitioner. Alternatively, if a brain abnormality was de-
tected on iuMR imaging, the findings were discussed with
the relevant fetal maternal consultant and a full clinical
style report was issued. Mean and standard deviation were
calculated for each of the four intracranial volumes mea-
sured in the fetuses with CHD, and scatterplots were pro-
duced plotting gestational age against the intracranial vol-
ume of interest alongside the data obtained from 200 nor-
mal fetuses [17]. Multiple linear regression models were
produced for each intracranial volume measured adjusting
for gestational age. Only normal cases scanned between
gestational weeks 28 to 36 (n = 95) were included in that
analysis as there were no fetuses with cardiac abnormali-
ties outside that range. Z scores were calculated for each
volume measurement in each fetus with CHD by compar-
ison with the mean and standard deviation values of nor-
mal fetuses of the appropriate gestational week. Z scores
were also used to correlate changes in volume changes
from the four intracranial compartments.
Results
Twenty pregnant women carrying a fetus with CHD were
initially recruited, but four did not attend the iuMR ap-
pointment; so, 16 fetuses with CHD were reported and are
summarised in Table 1. The iuMR studies of the 16 fe-
tuses with CHD were scanned between 28 and 36 gw, and
in all cases, diagnostic quality of both 2D and 3D volume
images were obtained within a 30-min table occupancy
time.
Intracranial structural abnormalities were recognized on
2D imaging in 5/16 (31%) fetuses with CHD and consisted
of ventriculomegaly as the only intracranial structural ab-
normality in 3/16 and hypoplasia of the cerebellar vermis
in two cases (one with ventriculomegaly as well; Table 1
and Fig. 3). In both cases, the hypoplasia of the vermis was
involved the inferior portion, specifically the portion
Fig. 3 A fetus from this study
(case #2 on Table 1) with known
double outlet right ventricle and
transposition of the great arteries
but no brain abnormality on USS.
Inferior vermian hypoplasia was
shown on iuMR performed at 33
gestational weeks (a sagittal and b
coronal) along with mild
ventriculomegaly and bilateral
cleft lip/palate (a and c coronal)
606 Neuroradiology (2019) 61:603–611
caudal to the pre-pyramidal fissure. Table 1 also shows the
Z scores for VV, TBV, EAV, and TICV for the group of 16
fetuses with CHD when compared with the mean and stan-
dard deviations of the age-matched normal fetuses. 11/16
fetuses with CHD had TBV below the mean (i.e., negative
Z scores), 14/16 fetuses had EAV below the mean, and 13/
16 fetuses had TICV below the mean. In contrast, 12/16
fetuses with CHD had VV above the mean. Figure 4a–d
shows distribution of the VV, TBV, EAV, and TICV for
CHD fetuses against the normal cases, and the results of
the regression models for these cases are shown in Table 2.
Fetuses with CHD have statistically significant reductions
in TBV, EAV, and TIBV, while VV was significantly larger
when compared with controls after adjustment for gesta-
tional age.
The correlation between Z scores for VV, EAV, and TICV
compared with BPV for the fetuses with CHD is shown in
scatterplots (Fig. 5a–c). Those results show that there is a
strong positive correlation between TICVand BPV (Fig. 5c),
a moderate positive correlation between EAV and BPV
(Fig. 5b), and a very weak negative correlation between VV
and BPV (Fig. 5a).
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Fig. 4 Distribution of the ventricular volume (a VV), brain parenchymal
volume (b BPV), extra-axial volume (c EAV), and total intracranial vol-
ume (d TICV) for fetuses with congenital heart disease (red triangles)
with the volumes measured in normal fetuses (blue circles). A summary
of the statistical analysis is shown in Table 2
Table 2 Results of multiple linear
regression models on the four
volume measures adjusting for
gestational age
Anatomical compartment Adjusted mean difference (95% confidence intervals) p value
Ventricular volume (mm3) + 1.83 (+ 0.67, + 2.99) 0.002
Total brain volume (mm3) − 19.2 (− 29.9, − 8.5) < .001
Extra-axial volume (mm3) − 30.6 (− 40.3, − 21.0) < .001
Total intracranial volume (mm3) − 48.0 (− 63.8, − 32.2) < .001
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Fig. 5 Correlation of brain
parenchymal volume with
ventricular volume (a), extra-
axial volume (b), and total
intracranial volume in 16 fetuses
with CHD. See text for details
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Discussion
It has been possible to obtain high-quality ultrafast 2D images
for many years, but in this paper, we have shown that it is
possible to obtain high-quality, ultrafast 3D volume acquisi-
tions of the fetal brain routinely in women with pregnancies
complicated by CHD of the fetus in times that are appropriate
for clinical investigations (table occupancy ≤ 30 min).
Individual 2D and 3D acquisitions are obtained in 20–30 s,
so that multiple attempts to obtain successful acquisitions can
be made during the 30-min scan event. The most time-
intensive stage of the process at present is the manual segmen-
tation of the 3D datasets, which takes between 90 and 180 min
depending on the complexity of the surface of the cortical
plate/cerebral cortex.
Our prospective study showed that 5/16 (31%) of fe-
tuses with CHD had intracranial structural abnormalities
on iuMR imaging that were not detected on USS, which is
similar to the 39.6% in an earlier report of Mlczoch [20]
but higher than in two other reports [21, 22] as interpreted
below. Two of our cases had abnormalities of the cerebel-
lar vermis, and the other three showed varying degrees of
ventriculomegaly as the only intracranial finding. We con-
sider that all of those abnormalities are likely to be devel-
opmental in nature as there was no evidence of ischaemic
injury, hemorrhage, or encephalomalacia to account for
the cases of ventriculomegaly. The previously described
systematic review [15] did not attempt to make a compar-
ison of detection rates between iuMR and USS studies,
but one of the studies used in the systematic review
showed structural intracranial abnormalities in 23% of fe-
tuses (33/144) with CHD with no extra-cardiac abnormal-
ities on USS. Ten of the abnormalities consisted of en-
largement of the extra-axial CSF spaces—a diagnosis that
does not feature as a discrete intracranial structural abnor-
mality in our analysis. If those cases are excluded, the
abnormality rate becomes 16% (including 12 cases of
mild ventriculomegaly and three fetuses with inferior
vermian hypoplasia). Mlczoch et al., in contrast, did not
attempt comparison between iuMR and USS findings but
found intracranial abnormalities on iuMR in 39% (21/55)
[20]. This group also includes nine cases of Bchanges of
CSF spaces^ that would not have been considered abnor-
mal using the criteria used in our study, altering their
results to 22%. 7/12 of the Btrue^ brain abnormalities
resulted from malformations (cortical formation abnor-
mality (3), agenesis of the corpus callosum (2),
holoprosencephaly (1), and cerebellar hypoplasia (1)),
and 5/12 were thought to be acquired brain pathology
(ventriculomegaly and/or ventricular bleeding (3) and
germinolytic cysts (2)).
The number of studies of brain volume in fetuses with
CHD reported in the systematic review of Khalil et al.
[15] was small (seven studies, retrospective, not formally
powered, and USS and MR methods were grouped to-
gether), but 6/7 of those described reduced brain volumes
in CHD cases. Five of the studies looked at unselected
forms of CHD (like our present study), four showed re-
duced brain volumes in CHD (three using iuMR and one
using USS), and one USS-based study did not find a dif-
ference in brain volumes. The results of our study are in
broad agreement with the findings of the systematic re-
view as we have also shown statistically reduced brain
volumes (i.e., reduced BPV). The major advantage of
our approach is the ability to measure the other intracra-
nial compartments as well as brain per se. This was also
the approach of one study included in the systematic re-
view, but only studied fetuses with Tetralogy of Fallot
[22]. As such, we found that the fetuses with CHD had
statistically smaller EAV and TICV, while their VV was
increased. We also showed that there was a strong posi-
tive correlation between BPV and TICV, a moderate pos-
itive correlation between BPV and EAV, and a weak neg-
ative correlation between BPV and VV. This allows a
better assessment of the possible etiological cause of the
reduced BPV as different pathologies are expected to af-
fect the intracranial compartments differently.
Before attempting to explain the small size of brains
from fetuses with CHD, it is important to review the nor-
mal circulation in the fetal heart, which is shown diagram-
matically in Fig. 6a. It is a fundamental anatomical feature
of the fetal heart to keep blood flow to the non-inflated
lungs to a minimum, and this is achieved by shunting
blood from the right atrium to the left atrium via the fora-
men ovale and from the pulmonary artery to the descend-
ing aorta via the ductus arteriosus. A superficial analysis of
this arrangement might lead to the assumption that oxygen-
ation levels in the blood are the same in all parts of the left
side of the heart and in the major outflow tracts. However,
Donofrio and Massaro [7] describe subtle, but important
changes in intracardiac flow that maximize oxygen supply
to the fetal brain (via the carotid and vertebral arteries) and
to the fetal heart (via the coronary arteries), which are
based primarily on ovine studies. Blood return to the right
atrium comes from two sources, the superior and inferior
vena cavae, and in the fetus, (unlike the adult) there is a
marked difference in the oxygenation levels of blood in
those veins. Blood in the inferior vena cava has higher
levels of oxygenated blood because of the ductus venosus,
which carries maternally derived oxygen via the placenta
and umbilical vein. The superior vena cava, in contrast,
carries high levels of deoxygenated blood from the fetal
head, neck, and upper limbs. Donofrio and Massaro pro-
pose that blood from the superior vena cava (with low
levels of oxygen) is directed into the right ventricle, while
the eustachian valve directs oxygenated venous return
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from the inferior vena cava mainly into the left atrium via
the foramen ovale [7]. Thus, the left side of the heart has
higher levels of oxygenated blood when compared with the
right side. Most of the cardiac output from the right ven-
tricle (with low levels of oxygen) is shunted from the pul-
monary arteries via the ductus arteriosus into the descend-
ing aorta where it passes to the lower part of the fetal body
(the ductus arteriosus is attached distal to the origins of the
carotid and vertebral arteries). So, the deoxygenated blood
passes to the lower part of the fetal body and placenta,
rather than to the brain. In contrast, blood with high oxy-
gen levels in the left ventricle passes into the ascending
and arch of the aorta and hence into the carotid and verte-
bral arteries. As a result, the normal fetal brain receives as
much oxygen as possible.
The anatomically more severe forms of CHD interfere
with this normal, selective passage of oxygenated blood
to the fetal brain and produce intracardiac mixing with
blood with lower oxygen tension. A good example occurs
in transposition of the great arteries (6b) where all of the
deoxygenated blood in the right ventricle is directed to-
wards the cranio-cervical arteries and fetal brain [7].
Similar problems are encountered in fetuses with truncus
arteriosus, Tetralogy of Fallot, and hypoplastic left heart
syndrome [7]. Donofrio and Massaro propose that the ab-
normal mixing of intracardiac blood in those types CHD
is associated with changes in fetal cerebral blood flow that
can be detected and measured by Doppler USS. Kaltman
for example showed that cerebral pulsatility index was
abnormal in 7% of fetuses with CHD, all of whom had
anomalies that were expected to produce abnormal cardiac
mixing, which was interpreted as indicating vasodilation
and increased flow in the cerebral vessels in order to
compensate for specific cerebral hypoxemia [23]. We
have not attempted a formal subgroup analysis examining
intracranial volumes in different types of CHD because of
the small number of cases in each category. We have
separated the cases that are expected to produce intracar-
diac mixing from those that do not in Table 1, and it is
clear that the severest reductions in BPV in our cohort
occurred in those with expected intracardiac mixing.
Our study has several strengths. We have only included
cases ≥ 28-week gestation who had a formal fetal echo
assessment by pediatric cardiologists and no chromosomal
or genetic abnormalities. We have excluded cases with
simple ventricular septal defect, abnormal venous circula-
tion, and or right aortic arch. We are the first group to
formally assess changes in subgroup of brain volumes.
The use of large number of control cases allowed formal
assessment of the changes. We acknowledge the small
number of cases included in our study and the inclusion
of mixed major cardiac anomalies, which does not allow
evaluation of each cardiac anomaly.
In summary, we describe a robust iuMR method to look
at the 2D structure and measure the volumes of the differ-
ent intracranial compartments of third trimester fetuses
with CHD. We have shown a high rate of structural brain
abnormalities that were not appreciated on USS and have
shown statistically significant reductions in BPV, EAV, and
TICV in those fetuses. Future large prospective adequately
powered case-control studies are required to judge the clin-
ical benefit of performing iuMR imaging in fetuses with
CHD and impact on counselling. Further work is required
to assess if associated structural abnormalities are directly
related to the impact of cardiac anomaly or miss diagnoses.
Counselling for major cardiac cases at 20-week gestation
should include the possibility of late identification of brain
anomalies in these cases.
Fig. 6 Diagrams indicating the pattern of blood flow in the normal foetal
heart and in transposition of the great arteries from [7]. See text for full
details but note that in the normal fetal heart (a), predominantly
oxygenated blood (labelled red) goes into the carotid arteries (and
hence the fetal brain), whereas in the fetus with transposition of the
great arteries (b), the carotid arteries contain predominantly de-
oxygenated blood (labelled blue) because the output of the right ventricle
passes into the ascending aorta
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